Edition:
United Kingdom

Agilent Technologies Inc (A.N)

A.N on New York Stock Exchange

77.90USD
13 Sep 2019
Change (% chg)

$0.33 (+0.43%)
Prev Close
$77.57
Open
$77.56
Day's High
$78.05
Day's Low
$77.27
Volume
365,200
Avg. Vol
611,325
52-wk High
$82.26
52-wk Low
$61.01

Latest Key Developments (Source: Significant Developments)

Agilent Technologies Announces Pricing Of $500 Million Of Senior Notes
Thursday, 5 Sep 2019 

Agilent Technologies Inc ::AGILENT TECHNOLOGIES ANNOUNCES PRICING OF $500 MILLION OF SENIOR NOTES.AGILENT TECHNOLOGIES INC - NOTES WILL MATURE IN SEPTEMBER 2029 AND WILL BEAR INTEREST AT AN ANNUAL RATE OF 2.750 PERCENT.  Full Article

Agilent Technologies Announces Proposed Offering Of Senior Notes
Thursday, 5 Sep 2019 

Sept 5 (Reuters) - Agilent Technologies Inc ::AGILENT TECHNOLOGIES ANNOUNCES PROPOSED OFFERING OF SENIOR NOTES.AGILENT - INTENDS TO USE NET PROCEEDS FROM OFFERING &, TO EXTENT NECESSARY, CASH ON HAND, TO FUND REDEMPTION OF ITS 5.00% SENIOR NOTES DUE 2020.  Full Article

Agilent Technologies Says Q3 GAAP Earnings Per Share $0.60
Wednesday, 14 Aug 2019 

Aug 14 (Reuters) - Agilent Technologies Inc ::AGILENT TECHNOLOGIES REPORTS THIRD QUARTER FISCAL YEAR 2019 FINANCIAL RESULTS.SEES Q4 2019 NON-GAAP EARNINGS PER SHARE $0.84 TO $0.86.Q3 NON-GAAP EARNINGS PER SHARE $0.76.Q3 GAAP EARNINGS PER SHARE $0.60.SEES Q4 2019 REVENUE $1.31 BILLION TO $1.33 BILLION.Q3 REVENUE $1.27 BILLION VERSUS REFINITIV IBES ESTIMATE OF $1.24 BILLION.SEES FY 2019 NON-GAAP EARNINGS PER SHARE $3.07 TO $3.09.SEES FY 2019 REVENUE $5.105 BILLION TO $5.125 BILLION.Q3 EARNINGS PER SHARE ESTIMATE $0.72 -- REFINITIV IBES DATA.RAISES FULL-YEAR REVENUE AND NON-GAAP EPS GUIDANCE.Q4 EARNINGS PER SHARE VIEW $0.87, REVENUE VIEW $1.34 BILLION -- REFINITIV IBES DATA.FY2019 EARNINGS PER SHARE VIEW $3.05, REVENUE VIEW $5.11 BILLION -- REFINITIV IBES DATA.  Full Article

Agilent Technologies Says Entered Amendment No.1 To Credit Agreement & Incremental Assumption Agreement Amending March 13 Dated Credit Agreement
Thursday, 8 Aug 2019 

Aug 8 (Reuters) - Agilent Technologies Inc ::AGILENT TECHNOLOGIES - ON AUG. 7, ENTERED AMENDMENT NO. 1 TO CREDIT AGREEMENT & INCREMENTAL ASSUMPTION AGREEMENT AMENDING MARCH 13 DATED CREDIT AGREEMENT.AGILENT SAYS INCREMENTAL AMENDMENT PROVIDES FOR A $500 MILLION 364-DAY, NON-AMORTIZING INCREMENTAL TERM FACILITY MATURING ON AUG. 5, 2020 - SEC FILING.  Full Article

Agilent Settles Key Intellectual Property Case In China
Thursday, 1 Aug 2019 

July 31 (Reuters) - Agilent Technologies Inc ::AGILENT SETTLES KEY INTELLECTUAL PROPERTY CASE IN CHINA.AGILENT TECHNOLOGIES- CO REACHED AGREEMENT WITH ECHROM AND PANNATEK, AS WELL AS CERTAIN FORMER AGILENT EMPLOYEES, REGARDING AN INTELLECTUAL PROPERTY DISPUTE.  Full Article

Agilent Companion Diagnostic Gains Expanded FDA Approval
Wednesday, 31 Jul 2019 

July 31 (Reuters) - Agilent Technologies Inc ::AGILENT COMPANION DIAGNOSTIC GAINS EXPANDED FDA APPROVAL IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESCC).U.S. FOOD AND DRUG ADMINISTRATION HAS APPROVED COMPANY'S PD-L1 IHC 22C3 PHARMDX ASSAY FOR EXPANDED USE.  Full Article

Twist Bioscience-On Dec 7, Court Granted Agilent's Motion To Amend Its Complaint, Permitting Agilent To File Its Second Amended Complaint
Monday, 10 Dec 2018 

Dec 10 (Reuters) - Twist Bioscience Corp ::TWIST BIOSCIENCE - ON DEC 7, COURT GRANTED AGILENT'S MOTION TO AMEND ITS COMPLAINT, PERMITTING AGILENT TO FILE ITS SECOND AMENDED COMPLAINT.TWIST BIOSCIENCE - AGILENT'S NEW COMPLAINT ADDS AMENDED ALLEGATIONS AGAINST CO & ITS CEO EMILY LEPROUST.TWIST BIOSCIENCE - AGILENT'S NEW COMPLAINT ADDS NEW CLAIMS FOR BREACH OF CONTRACT, TRADE SECRET MISAPPROPRIATION AGAINST SIYUAN CHEN, SOLANGE GLAIZE.TWIST BIOSCIENCE - THE COURT DENIED AGILENT’S MOTION FOR A PROTECTIVE ORDER, AND DID NOT SET ANY LIMITS ON DISCOVERY.TWIST BIOSCIENCE - ON DEC 7, COURT SET TRIAL WITH AGILENT TO START ON FEB 24, 2020.  Full Article

Agilent Technologies Increases Cash Dividend To 16.4 Cents Per Share
Wednesday, 14 Nov 2018 

Nov 14 (Reuters) - Agilent Technologies Inc ::AGILENT TECHNOLOGIES INCREASES CASH DIVIDEND TO 16.4 CENTS PER SHARE.  Full Article

Agilent Companion Diagnostic Gains Expanded FDA Approval In Cervical Cancer
Tuesday, 12 Jun 2018 

June 12 (Reuters) - Agilent Technologies Inc ::AGILENT COMPANION DIAGNOSTIC GAINS EXPANDED FDA APPROVAL IN CERVICAL CANCER.AGILENT TECHNOLOGIES INC - FDA HAS APPROVED ITS DAKO PD-L1 IHC 22C3 PHARMDX ASSAY FOR EXPANDED USE.  Full Article

Alnylam Pharma Co, Agilent Technologies Entered Manufacturing Services Agreement Providing For Supply Of Patisiran Drug Substance By Agilent
Tuesday, 3 Apr 2018 

April 4 (Reuters) - Alnylam Pharmaceuticals ::CO, AGILENT TECHNOLOGIES ENTERED MANUFACTURING SERVICES AGREEMENT PROVIDING FOR SUPPLY OF PATISIRAN DRUG SUBSTANCE BY AGILENT.AGREEMENT HAS INITIAL TERM OF 5 YEARS, WHICH IS SUBJECT TO AUTOMATIC RENEWAL TERMS OF 2 YEARS.PURSUANT TO AGREEMENT, CO REQUIRED TO PROVIDE ROLLING FORECASTS FOR PRODUCT ON QUARTERLY BASIS.‍PURSUANT TO DEAL, AGILENT HAS AGREED TO MANUFACTURE, SUPPLY TO CO, ACTIVE PHARMACEUTICAL INGREDIENTS REQUIRED FOR PATISIRAN FOR COMMERCIAL SALE​.WILL BE REQUIRED TO PROVIDE INITIAL PAYMENT TO COVER RAW MATERIAL PURCHASES AND RESERVE APPROPRIATE RESOURCES UNDER AGREEMENT.  Full Article

WHO updates its essential medicines list, adds cancer and stroke drugs

GENEVA, July 9 The World Health Organization published an updated list of "essential medicines" on Tuesday, adding drugs for cancer, stroke, rheumatoid arthritis and inflammatory bowel disease among the treatments that should be seen as the standard.